Nick Roberts
Fortuna: 122 401 $ al 31/05/2026
Fortuna: 122 401 $ al 31/05/2026
Nick Roberts currently works at Diaceutics Plc, as Chief Financial Officer & Director from 2022.
Mr. Roberts also formerly worked at Ceres Power Holdings plc, as Group Financial Controller from 2015 to 2020 and Ergomed Group Ltd., as Head-Group Reporting from 2020 to 2022.
Mr. Roberts received his undergraduate degree from The University of Southampton.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
DIACEUTICS PLC 0,07 % | 30/03/2026 | 63.500 ( 0,07 % ) | 122 401 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| DIACEUTICS PLC | Director Financiero/CFO | 18/03/2022 |
| Empresas | Cargo | Fin |
|---|---|---|
| ERGOMED | Corporate Officer/Principal | 01/03/2022 |
| CERES POWER HOLDINGS PLC | Comptroller/Controller/Auditor | 01/01/2020 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Ceres Power Holdings plc
Ceres Power Holdings plc Electronic Production EquipmentElectronic Technology Engages in development and commercialization of fuel cell technology | Electronic Technology |
The University of Southampton
The University of Southampton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ergomed Plc
Ergomed Plc BiotechnologyHealth Technology Engages in research and development of drugs for oncology & rare diseases | Health Technology |
Diaceutics Plc
Diaceutics Plc BiotechnologyHealth Technology Engages in research and development in medicine drug development and diagnostic tests development | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.